Contribution: Industrial Research Assistance Program – Contributions to Firms
ELAREX INC.
$75,000.00
MNC Collab - IEVSSP - IAVI Elarex VSV Stability Study POC
FY 2024-25 · 2024-11-01
Summary
As part of Multinational Corporate Collaboration Program, the project “IAVI Elarex VSV Stability Study POC” will focus on proving that the Elarex formulation and process to stabilize a VSV vectored vaccine, is effective when used with IAVI's Marburg virus vaccine.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Burlington|Burlington, Ontario, Canada
Recipient Type
For-profit organization
Business Number
756228474
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-11-01 | 2024-25 | $75,000.00 |
| 1 | 2024-11-01 | 2024-25 | $75,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 160 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 160 jours.
Agreement End Date
2025-07-31
Agreement Number
1023443
Agreement Start Date
2024-11-01
Agreement Title
MNC Collab - IEVSSP - IAVI Elarex VSV Stability Study POC
Agreement Title (French)
Collaboration MNC - IEVSSP - PDC de l’étude de stabilité du VSV Elarex de l’IAVI
Agreement Type
Contribution
Agreement Value
$75,000.00
Amendment Date
2025-02-13
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
As part of Multinational Corporate Collaboration Program, the project “IAVI Elarex VSV Stability Study POC” will focus on proving that the Elarex formulation and process to stabilize a VSV vectored vaccine, is effective when used with IAVI's Marburg virus vaccine.
Description (French)
Dans le cadre du programme de collaboration entre entreprises multinationales, le projet « PDC de l’étude de stabilité du VSV Elarex de l’IAVI» visera à prouver que la formulation et le processus d’Elarex pour stabiliser un vaccin vectoriel VSV sont efficaces lorsqu’ils sont utilisés avec le vaccin contre le virus de Marburg de l’IAVI.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Burlington
Federal Riding (French)
Burlington
Federal Riding Number
35015
NAICS Code
54171
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
756228474
Recipient City
Burlington|Burlington
Recipient Country
CA
Recipient Legal Name
ELAREX INC.
Recipient Operating Name
Elarex
Recipient Postal Code
L7L 4X5
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2024-2025-Q3-1023443
